Clinical Trial Update: Safety Escalating Repeat IV, in Stroke Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting results for escalating repeat intravenous administration in patients with transient ischemic attack and ischemic stroke. Results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Snippet

Sponsor: GlaxoSmithKline | Conditions: Ischaemic Attack, Transient | Phase 2 | Status: COMPLETED | Results posted: 2017-10-16